The Beauty Health Company shares are trading lower after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $11 to $1.5.
Portfolio Pulse from Benzinga Newsdesk
The Beauty Health Company's stock (SKIN) is trading lower following a downgrade by Jefferies from Buy to Hold and a significant reduction in the price target from $11 to $1.5.
November 15, 2023 | 6:39 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The Beauty Health Company's stock price is expected to face downward pressure in the short term due to the downgrade by Jefferies and a drastic cut in the price target.
Analyst downgrades and price target reductions typically lead to negative investor sentiment and can cause a stock's price to decline in the short term. The severity of the downgrade from Buy to Hold and the substantial decrease in the price target from $11 to $1.5 suggest a significant change in the company's valuation, which is likely to be taken seriously by the market.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100